Literature DB >> 20207367

Neuromuscular disorders associated with Hepatitis B vaccination.

Joerg-Patrick Stübgen1.   

Abstract

The hepatitis B virus (HBV) is an important infectious cause of acute and chronic liver disease throughout the world. Recombinant hepatitis B vaccines have been developed to combat morbidity and mortality associated with HBV infection. These vaccines have been associated with autoimmune diseases mostly among adult vaccine recipients. Epidemiological surveys have not established unequivocal causality between the hepatitis B vaccine and the development of various autoimmune neuromuscular disorders. However, case histories and series hint at a temporal association between hepatitis B vaccines and the development of various neuropathy syndromes, polyarteritis nodosa complicated by vasculitic neuropathy, myasthenia gravis and dermatomyositis. Conceivably, the hepatitis B vaccines have a potential to occasionally trigger the onset of immune diseases in individuals with an underlying genetic or immunological susceptibility. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207367     DOI: 10.1016/j.jns.2010.02.016

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  On hepatitis B virus and vasculitis.

Authors:  Resat Ozaras; Aslihan Demirel; Suleyman Uraz; Bilgul Mete; Fehmi Tabak
Journal:  Rheumatol Int       Date:  2018-06-13       Impact factor: 2.631

Review 3.  Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review.

Authors:  Feng Wang; Tao Xiang; Lanying He; Jian Wang
Journal:  Hum Vaccin Immunother       Date:  2021-09-24       Impact factor: 4.526

Review 4.  Myasthenia gravis and infectious disease.

Authors:  Nils Erik Gilhus; Fredrik Romi; Yu Hong; Geir Olve Skeie
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

5.  Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.

Authors:  Josette Cadusseau; Nilusha Ragunathan-Thangarajah; Mathieu Surenaud; Sophie Hue; Francois-Jérôme Authier; Romain K Gherardi
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

6.  Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA).

Authors:  Nancy Agmon-Levin; Yaron Zafrir; Shaye Kivity; Ari Balofsky; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 4.505

Review 7.  Hepatitis B vaccination and associated oral manifestations: a non-systematic review of literature and case reports.

Authors:  B Tarakji; N Ashok; R Alakeel; Sn Azzeghaibi; A Umair; S Darwish; Rs Mahmoud; E Elkhatat
Journal:  Ann Med Health Sci Res       Date:  2014-11

Review 8.  Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.

Authors:  Juqiang Han; Shuai Wang; Thomas Ngai Yeung Kwong; Jian Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

9.  Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis.

Authors:  Dan He; Han Zhang; Jun Xiao; Xiaofan Zhang; Minjie Xie; Dengji Pan; Minghuan Wang; Xiang Luo; Bitao Bu; Min Zhang; Wei Wang
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

Review 10.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.